# ArtiAid® Plus for Knee Osteoarthritis: A Post-market Study

> **NCT05881317** · NA · COMPLETED · sponsor: **Maxigen Biotech Inc.** · enrollment: 59 (actual)

## Conditions studied

- Hyaluronic Acid

## Interventions

- **DEVICE:** ArtiAid® Plus Intra-articular Injection

## Key facts

- **NCT ID:** NCT05881317
- **Lead sponsor:** Maxigen Biotech Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-08-02
- **Primary completion:** 2022-06-06
- **Final completion:** 2022-11-21
- **Target enrollment:** 59 (ACTUAL)
- **Last updated:** 2023-05-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05881317

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05881317, "ArtiAid® Plus for Knee Osteoarthritis: A Post-market Study". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT05881317. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*